NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Exclusion Criteria

• •Contra-indication for surgery
• •Uncontrolled oesophageal gastric reflux despite optimal treatment
• •Thoracic deformation (For example, pectus excavatum/carinatum or major scoliosis)
• •Risk of pleural adhesion (For example, patient who has already undergone thoracic surgery)
• •History of abnormal bleeding
• •Predictable risk of difficult intubation
• •Body mass index (BMI) \> 30
• •Severe cardiovascular comorbidity (For example, instable ischemic cardiomyopathy)
• •Unable to comply with all trial procedures/visits (For example, language barriers, upcoming move of household to another region, unwillingness to schedule the required followup visits.)
• •Protected populations according to the French Public Health Code Articles L1121-5,6,8 (For example, pregnant, parturient or lactating women, prisoners, adults under guardianship or otherwise unable to consent.)
• •Potential interference from another study (The patient is participating in another interventional study, or has done so in the past month, or is affected by an exclusion period stipulated by a previous study.)
• •Non-beneficiary of the French single-payer national medical insurance system
• •Lack of signed informed consent